Pfizer said to be in takeover talks with Actavis
Acquisition could allow the US drugmaker to move overseas and reduce taxes
M&A activity up 31.1 per cent in first half of the year
New figures indicate M&A activity in Ireland is at its strongest since the early 2008
Ireland’s tax regime comes under US spotlight again
United States congress reveals scale of corporate relocations to cut taxes
Dundalk has got back its business groove
Initiatives to bring jobs and investment to Dundalk have had some success in recent years
Pfizer’s designs on AstraZeneca stir tax envy among rivals
Pitching by bankers on tax inversion targets has reached fever pitch
Cantillon: Actavis clears first hurdle in $25bn Forest deal
The deal is predicated on the now familiar model of acquire, slash costs and point to advances in the share price
Dublin-based Actavis to buy Forest Labs for $25 billion
Actavis will pay the equivalent of $89.48 per share for US pharma company
Actavis sells businesses in western Europe to Aurobindo
Largest generic drugs manufacturer in the US opts to focus on faster-growing markets but is also withdrawing from China
US firms cut taxes by relocating to Europe after takeovers
US pharma group Perrigo says acquisition of Elan will lead to redomiciling in Ireland
Cantillon: Making sense of confusion in mid-range pharma M&A
Cluster of recent deals could each have an impact on Irish drug sector
Actavis to buy Warner Chilcott in $5 billion stock deal
Irish domicile of target company an attraction for generic drug maker
YOU MAY ALSO LIKE...
Crosswords & Puzzles
Crosswords & puzzles to keep you challenged and entertained
Election 2024
Full general election coverage including analysis and results for all 43 constituencies
Common Ground
How does a post-Brexit world shape the identity and relationship of these islands
Family NoticesOpens in new window
Weddings, Births, Deaths and other family notices